Arming Preclinical Cancer Research Through Enhanced Model Confidence
The Tumor Models Conference Series is dedicated to exploring the latest advances in the application of preclinical models to enhance the translation of cancer therapies from bench to patient.
Sitting at the interface of model innovation and therapeutic development, the event brings together a multidisciplinary mix of model developers, translational and pharmacology research scientists. It facilitates an environment of knowledge sharing and debate to actively assess how the industry is overcoming challenges in drug development through the use of in vitro & in vivo models.
Designed with input from thought leaders from over 40 organizations this represents your opportunity to benchmark your progress and enhance the translational confidence of your preclinical approaches.
Bringing together a multidisciplinary mix of participants, from academia, industry and model providers, this is your opportunity to join 150 attendees from 80 organizations to define the future of cancer drug.